More than 75 of the UK's leading scientists, clinicians and industry experts gathered at an Imperial Business Partners' event in September.
The event, Future directions: mRNA technology in the UK, examined the current landscape of mRNA technologies, the role of artificial intelligence in vaccine creation and clinical applications of mRNA technology.
A customized collection of grant news from foundations and the federal government from around the Web.
Nonprofit impact investing firm, Acumen, has invested $1.2 million to KZ Noir, a Rwanda-based coffee processing company owned by Kaizen Venture Partners. The investment will equip KZ Noir the funds for working capital, debt refinancing, and capacity expansion.